Taken together, normalized results indicate that lack of USP21 increases sensitivity of cancer cells to both nonspecific anticancer drug such as DOX and specific mitochondrial inhibitors, resulting in distortion of cellular bioenergetics and cell viability (Fig. 5, C–E). Here, USP21 is linked to cancer.